Terminated PHASE3 INTERVENTIONAL 2-arm NCT01117051

Prucalopride Effects on Subjects With Chronic Non-cancer Pain Suffering From Opioid Induced Constipation (OIC)

A 12-week, Randomised, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Prucalopride in Subjects With Chronic Non-cancer Pain Suffering From Opioid Induced Constipation

Sponsor: Shire

Conditions Non-cancer Pain Opioid Induced Constipation

Interventions placebo prucalopride

Updated 7 times since 2017 Last updated: May 19, 2021 Started: May 19, 2010 Primary completion: Aug 13, 2012 Completion: Aug 13, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

The study was stopped by the sponsor based on a non-safety related business priority decision

Other terminated trials from Shire

See all terminations from Shire

A PHASE3 clinical study on Non-cancer Pain and Opioid Induced Constipation, this trial is terminated or withdrawn. The trial is conducted by Shire and has accumulated 7 data snapshots since 2010. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Dec 2021 — Jul 2024 [monthly]

Terminated PHASE3
Sep 2021 — Dec 2021 [monthly]

Terminated PHASE3
Jan 2021 — Sep 2021 [monthly]

Terminated PHASE3

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE3

First recorded

May 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shire

Data source: Takeda

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Leuven, Belgium